A Placebo Controlled, Double-blind, Multi-centre, Single Dose, Parallel Group, Randomised Clinical Trial of GSK2862277 in Patients Undergoing Oesophagectomy Surgery
Phase of Trial: Phase II
Latest Information Update: 27 Apr 2017
At a glance
- Drugs GSK 2862277 (Primary)
- Indications Adult respiratory distress syndrome
- Focus Pharmacodynamics
- Sponsors GlaxoSmithKline
- 07 Jun 2017 Biomarkers information updated
- 23 Feb 2017 Planned End Date changed from 1 Nov 2017 to 1 Nov 2018.
- 01 Aug 2016 Planned End Date changed from 1 Sep 2017 to 1 Nov 2017.